Vichy Laboratoires International

The idea that topical actives can make skin "produce its own collagen" isn't a marketing stretch: it's a documented mechanism for several ingredient families. A clinical study published in Dermatology and Therapy (2024) shows a formulation combining retinol, a pea peptide (Pep_RTE62G), and antioxidants increases collagen (COL1A1) and elastin gene expression in skin co-cultures, with measured gains in hydration and elasticity clinically after 8 weeks. Another study (Journal of Drugs in Dermatology, 2024, Whitney Bowe et al.) shows a retinaldehyde-and-firming-peptide serum visibly reduces fine lines within 8 weeks in women, including those with skin of color. Retinol's mechanism is also well characterized: it regulates over 3,000 genes in keratinocytes and fibroblasts, increases procollagen synthesis, and inhibits the matrix metalloproteinases that break down existing collagen. What the Vichy ad doesn't provide, though, is the specific ingredient list for "Collagen 16" or an independent (non-brand-sponsored) study demonstrating that this specific serum triggers endogenous stimulation in humans. Verdict: mixed — the "a topical active stimulates the skin's own collagen" mechanism is real and well documented for comparable formulations, but nothing confirms it applies precisely to this product absent published, independent data on "Collagen 16."